ERYTECH Pharma S.A., a clinical-stage biopharmaceutical company, develops red blood cell-based therapeutics for severe forms of cancer and orphan diseases. The company's lead product candidate is eryaspase, which is in Phase III clinical development for the treatment of second-line pancreatic cancer and in Phase II stage for the treatment of triple-negative breast cancer. ERYTECH Pharma S.A. has research collaboration with the Fox Chase Cancer Center to advance the preclinical development of erymethionase for the treatment of homocystinuria; and Queen's University of Canada to advance the preclinical development of eryminase for the treatment of arginase-1-deficiency. ERYTECH Pharma S.A. was founded in 2004 and is headquartered in Lyon, France.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [03/31/2020 11:07 PDT] ERYTECH Pharma S.A. (NASDAQ:ERYP), Up By 100.00% ($4.79) From $4.790 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/31/2020 11:07 PDT] ERYTECH Pharma S.A. (NASDAQ:ERYP), Up By 100.00% ($4.79) From $4.790 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/31/2020 11:07 PDT] ERYTECH Pharma S.A. (NASDAQ:ERYP), Up By 100.00% ($4.79) From $4.790 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/30/2020 08:21 PDT] ERYP Expected to Trade Up After Bullish Patterns Develop
• [03/27/2020 08:24 PDT] ERYP Expected to Trade Up After Bullish Patterns Develop
• [03/26/2020 08:29 PDT] ERYP Expected to Trade Up After Bullish Patterns Develop
• [03/17/2020 11:07 PDT] ERYTECH Pharma S.A. (NASDAQ:ERYP), Down By 100.00% ($4.50) From $4.500 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/17/2020 08:00 PDT] ERYP Expected to Trade Down After Bearish Patterns Develop
• [02/28/2020 07:49 PST] ERYP Expected to Trade Up After Bullish Patterns Develop
• [02/27/2020 07:32 PST] ERYP Expected to Trade Up After Bullish Patterns Develop